Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Vital Paulino Costa, Tin Aung & Anastasios G. Konstas. (2019) Evolution of the treatment paradigm for maximum medical therapy in glaucoma. Expert Review of Ophthalmology 14:1, pages 33-42.
Read now
Read now
Leopoldo Martín Baiza-Durán, Juan Francisco Llamas-Moreno & Clotilde Ayala-Barajas. (2012) Comparison of timolol 0.5% + brimonidine 0.2% + dorzolamide 2% versus timolol 0.5% + brimonidine 0.2% in a Mexican population with primary open-angle glaucoma or ocular hypertension. Clinical Ophthalmology 6, pages 1051-1055.
Read now
Read now
Articles from other publishers (4)
Tao Wang, Linlin Cao, Qikun Jiang & Tianhong Zhang. (2021) Topical Medication Therapy for Glaucoma and Ocular Hypertension. Frontiers in Pharmacology 12.
Crossref
Crossref
Thomas V. Johnson & Henry D. Jampel. (2020) Intraocular Pressure Following Prerandomization Glaucoma Medication Washout in the HORIZON and COMPASS Trials. American Journal of Ophthalmology 216, pages 110-120.
Crossref
Crossref
R D Fechtner, J S Myers, D A Hubatsch, D L Budenz & H B DuBiner. (2016) Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial. Eye 30:10, pages 1343-1350.
Crossref
Crossref
Francesco Pichi & Careen Y. Lowder. 2014. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions
873
887
.